Nature5y
Unlocking the secrets of PD-L1 signalling
Cancer immunotherapies are saving lives ... such as antigen-presenting cells — which also express PD-L1, in the surrounding microenvironment (see ‘How tumour cells hide’).
EurekAlert!2d
Ability of large language models to extract PD-L1 biomarker details from electronic health records
A new study, published in the peer-reviewed journal AI in Precision Oncology, examines the ability of large language models ...
The American Journal of Managed Care3d
First-Line Tislelizumab Plus Chemotherapy Approved in ESCC Expressing PD-L1
Tislelizumab plus chemotherapy received FDA approval as a frontline therapy for individuals with unresectable or metastatic ...
European Medical Journal14d
New Strategy Enhances PD-1 Therapy in Treatment-Resistant Cancers
A new study shows that neutralising GDF-15 restores immune response in advanced cancers resistant to PD-1 blockade.
Precision Medicine Online3d
FDA Approves BeiGene's Tevimbra in First-Line PD-L1-Positive Esophageal Cancers
Patients with PD-L1-positive tumors lived more than seven months longer on Tevimbra added to chemotherapy compared to just chemo.
CURE14d
Ficerafusp Alfa Trial Begins for Recurrent/Metastatic Head and Neck Cancer
Ficerafusp alfa enters phase 2/3 trial for recurrent/metastatic head and neck cancer, evaluating its combination with ...
Finely tuned large language models can extract PD-L1 biomarker details from electronic health records
A new study published in AI in Precision Oncology examines the ability of large language models (LLMs) to rapidly extract ...